Article: CYTOTHERAPEUTICS CUTS BACK OPERATIONS, CHANGES FOCUS.

CytoTherapeutics Inc. cut its staff by 60 and, in a reorganizational effort, will focus now on its proprietary stem cell technology platform through its wholly owned subsidiary, StemCells Inc.

In addition, the Lincoln, R.I., company expects to reduce substantially its research and manufacturing facility in Lincoln. The company had 75 employees at its headquarters and another 15 at StemCells, which is located in Sunnyvale, Calif. No cuts were made in California.

"It's obviously very disappointing when you have to cut back, but our lead program failed," said Richard Rose, president and chief executive officer. "So we are now shifting our focus into stem ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!